Literature DB >> 8294093

Reperfusion injury, antioxidants and hemodynamics during orthotopic liver transplantation.

H F Goode1, N R Webster, P D Howdle, J P Leek, J P Lodge, S A Sadek, B E Walker.   

Abstract

Endothelial injury occurs as a result of oxygen free radical production after ischemia and reperfusion of transplanted livers, causing hemodynamic disturbance. Patients with chronic liver disease generally have low levels of fat-soluble vitamins, which have important antioxidant roles. We therefore assessed circulating levels of the antioxidants vitamin A, vitamin E, beta-carotene and lycopene, indices of lipid peroxidation and hemodynamic changes during elective orthotopic liver transplantation in 12 patients. We found that initial antioxidant levels were severely depleted compared with healthy subjects, and in some patients carotene and lycopene levels were undetectable. Increased lipid peroxidation was also evident, as shown by thiobarbituric acid-reactive substances. On reperfusion of the liver graft, vitamin A and E levels fell (p < 0.01) and were associated with decreases in systemic vascular resistance (p < 0.02). These data show that patients undergoing liver transplant have lowered antioxidant defenses and evidence of free radical damage, which compound the additional insult of reperfusion injury. Antioxidant therapy in these patients before transplantation may ameliorate the effects of reperfusion.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8294093

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  15 in total

1.  Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury.

Authors:  F Amersi; R Buelow; H Kato; B Ke; A J Coito; X D Shen; D Zhao; J Zaky; J Melinek; C R Lassman; J K Kolls; J Alam; T Ritter; H D Volk; D G Farmer; R M Ghobrial; R W Busuttil; J W Kupiec-Weglinski
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

Review 2.  Prospects for the use of antioxidant therapies.

Authors:  S R Maxwell
Journal:  Drugs       Date:  1995-03       Impact factor: 9.546

3.  Studies on hepatic injury and antioxidant enzyme activities in rat subcellular organelles following in vivo ischemia and reperfusion.

Authors:  M Gupta; K Dobashi; E L Greene; J K Orak; I Singh
Journal:  Mol Cell Biochem       Date:  1997-11       Impact factor: 3.396

4.  Minocycline protects against hepatic ischemia/reperfusion injury in a rat model.

Authors:  Yining Li; Tao Li; Haizhi Qi; Fang Yuan
Journal:  Biomed Rep       Date:  2014-11-11

5.  High prevalence of vitamin A deficiency and vitamin D deficiency in patients evaluated for liver transplantation.

Authors:  Mukund Venu; Eric Martin; Kia Saeian; Samer Gawrieh
Journal:  Liver Transpl       Date:  2013-04-15       Impact factor: 5.799

Review 6.  Therapeutic modulation of free radical-mediated reperfusion injury of the liver and its surgical implications.

Authors:  S Marubayashi; K Dohi
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

7.  The role of graft-resident Kupffer cells and lymphocytes of donor type during the time course after liver transplantation--a clinico-pathological study.

Authors:  Iris Bittmann; Adriana Bottino; Gustavo Bruno Baretton; Alexander Ludwig Gerbes; Reinhart Zachoval; Horst Günter Rau; Udo Löhrs
Journal:  Virchows Arch       Date:  2003-07-23       Impact factor: 4.064

8.  Bucillamine, a thiol antioxidant, prevents transplantation-associated reperfusion injury.

Authors:  Farin Amersi; Sally K Nelson; Xiu Da Shen; Hirohisa Kato; Judy Melinek; Jerzy W Kupiec-Weglinski; Lawrence D Horwitz; Ronald W Busuttil; Marcus A Horwitz
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-25       Impact factor: 11.205

9.  Protective effects of leflunomide against ischemia-reperfusion injury of the rat liver.

Authors:  Abdurrahman Karaman; Ersin Fadillioglu; Emine Turkmen; Erkan Tas; Zumrut Yilmaz
Journal:  Pediatr Surg Int       Date:  2006-03-24       Impact factor: 1.827

10.  Lazaroid U-74389G for 48-hour canine liver preservation.

Authors:  S Todo; N Hamada; Y Zhu; S Zhang; V Subbotin; A Nemoto; I Takeyoshi; T E Starzl
Journal:  Transplantation       Date:  1996-01-27       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.